|4May 12, 5:54 PM ET

FREYMAN THOMAS C 4

4 · AbbVie Inc. · Filed May 12, 2020

Insider Transaction Report

Form 4
Period: 2020-05-08
Transactions
  • Award

    Common Stock, $0.01 par value

    2020-05-08+2,333119,675 total
  • Award

    Common Stock, $0.01 par value

    2020-05-08+2,583117,342 total
Holdings
  • Common Stock, $0.01 par value

    (indirect: By Trust)
    4,000
Footnotes (3)
  • [F1]Received in exchange for 2,983 shares of Allergan plc common stock in connection with its acquisition by AbbVie Inc. Allergan shareholders received 0.8660 AbbVie shares for each Allergan share (based on the closing price of AbbVie's common stock of $84.22 on May 7, 2020).
  • [F2]These are restricted stock units awarded under the AbbVie 2013 Incentive Stock Program (the "Program"). They will be paid, on a one-to-one basis, in shares of AbbVie common stock on the earlier of the date of the director's separation from service, death, or the occurrence of a change in control (as defined in the Program).
  • [F3]The reporting person disclaims beneficial ownership of these securities.

Documents

1 file
  • 4
    edgar.xmlPrimary

    FORM 4 -